Lumbar Herniated Disc Clinical Trial
— O3HDCIRUGIAOfficial title:
Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study
Verified date | March 2024 |
Source | Dr. Negrin University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The main objective of this study is to estimate the cost-effectiveness of ozone therapy in patients on the waiting list for surgery due to disc herniation.
Status | Active, not recruiting |
Enrollment | 80 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Diagnosed with a herniated and not calcified lumbar disc that presents as: not migrated protrusion and/or extrusion. - Evaluated and diagnosed by the Neurosurgery Department, having been chosen as an appropriate candidate for surgery consisting in discectomy or microdiscectomy, after meeting the following two criteria: 1) Sciatic pain, with a visual analogue scale (VAS) intensity = 5, despite 6 weeks of conservative management, wether it exists lumbar pain or not and 2) Radiating pain that matches the MRI image showing one or more herniated discs (not to be considered those patients with two herniated discs and symptoms attributable to only one of the herniated discs). - Included in the surgery waiting list for a discectomy or microdiscectomy. - Patients who have signed and dated the study 's specific informed consent. Exclusion Criteria: - Patients who do not meet all the inclusion criteria. - Calcified and/or migrated herniated disc, and/or with a severe neurological deficits (cauda equine syndrome). - Herniated disc with surgical indication of laminectomy and/or arthrodesis (massive extrusion, sign of instability or other conditions under the neurosurgeon judgment). - Relevant clinical paresis that does not improve despite 6 weeks of full conservative management (patients with severe pain and mild paresis that only shows up in the physical exam are not to be excluded, but those who present with paresis as the main symptom -"clinically relevant"- must be). - Simultaneous symptomatic cervical or dorsal herniated discs. - Previous lumbar spine surgery. - Concomitant spine conditions that may be causing symptoms or have indication for surgery (such as fractures or tumors). - Known allergy to ozone. - Those who are uncapable to fill in the scales used to measure variables in the study, like the visual analogue scale (VAS), Roland-Morris and SF-12 questionnaires. - Those who are unable or do not wish to fulfill the study 's protocol (answer questions to collect the data). |
Country | Name | City | State |
---|---|---|---|
Spain | Dr. Negrin University Hospital | Las Palmas De Gran Canaria | Las Palmas |
Lead Sponsor | Collaborator |
---|---|
Bernardino Clavo, MD, PhD | Colegio Oficial de Médicos de Las Palmas, Instituto de Salud Carlos III, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Servicio Canario de Salud |
Spain,
Hansson E, Hansson T. The cost-utility of lumbar disc herniation surgery. Eur Spine J. 2007 Mar;16(3):329-37. doi: 10.1007/s00586-006-0131-y. Epub 2006 May 9. — View Citation
Luhmann D, Burkhardt-Hammer T, Borowski C, Raspe H. Minimally invasive surgical procedures for the treatment of lumbar disc herniation. GMS Health Technol Assess. 2005 Nov 15;1:Doc07. — View Citation
Magalhaes FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET. Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012 Mar-Apr;15(2):E115-29. — View Citation
Sherman J, Cauthen J, Schoenberg D, Burns M, Reaven NL, Griffith SL. Economic impact of improving outcomes of lumbar discectomy. Spine J. 2010 Feb;10(2):108-16. doi: 10.1016/j.spinee.2009.08.453. Epub 2009 Oct 12. Erratum In: Spine J. 2010 May;10(5):A8. — View Citation
Tosteson AN, Skinner JS, Tosteson TD, Lurie JD, Andersson GB, Berven S, Grove MR, Hanscom B, Blood EA, Weinstein JN. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976). 2008 Sep 1;33(19):2108-15. doi: 10.1097/brs.0b013e318182e390. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Direct Hospital Cost for patients included on waiting list for surgery due to disc herniation. | Euros | 24 months | |
Primary | Percentage of surgeries finally performed. | Percentage of surgeries performed after enrollment | 24 months | |
Primary | Change from Baseline in sciatic pain at 12 months | Visual Analogic Scale (VAS) | 12 months | |
Primary | Change from Baseline in sciatic pain at 24 months | Visual Analogic Scale (VAS) | 24 months | |
Secondary | Change from Baseline in sciatic pain at 6 months | Visual Analogic Scale (VAS) | 6 months | |
Secondary | Change from Baseline in lumbar pain at 6 months | Visual Analogic Scale (VAS) | 6 months | |
Secondary | Change from Baseline in lumbar pain at 12 months | Visual Analogic Scale (VAS) | 12 months | |
Secondary | Change from Baseline in lumbar pain at 24 months | Visual Analogic Scale (VAS) | 24 months | |
Secondary | Number of hospital stay days | Number of hospital stay days | 24 months | |
Secondary | Restriction of everyday activities | Spanish version of Roland-Morris questionnaire | 24 months | |
Secondary | Quality of life by 12-Item Short Form Survey (SF-12) | SF-12 questionnaire | 24 months | |
Secondary | Quality of life by the five-level version of the EuroQol five-dimensional (EQ-5D-5L) questionnaire | EQ-5D-5L questionnaire | 24 months | |
Secondary | Loss of labour productivity | Off work days (if applicable) | 24 months | |
Secondary | Time to resume normal activity | Days | 24 months | |
Secondary | Direct sanitary and non-sanitary costs incurred out of hospital. | Euros | 24 months | |
Secondary | Adverse effects | Number of serious adverse effects | 24 months | |
Secondary | Time from inclusion on waiting list for surgery to completion of the procedure. | Days | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01997086 -
Percutaneous Transforaminal Endoscopic Discectomy vs Microendoscopic Discectomy for Treatment of Lumbar Disc Herniation
|
Phase 4 | |
Enrolling by invitation |
NCT00927056 -
Evaluation of Minimally Invasive Microdiscectomy Versus Conventional Open Microdiscectomy For Lumbar Herniated Disc
|
N/A | |
Terminated |
NCT02414698 -
Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy
|
Phase 4 | |
Recruiting |
NCT03403244 -
US-MR Image Fusion-guided Percutaneous Transforaminal Endoscopic Discectomy for the Treatment of Lumbar Disc Herniation
|
N/A | |
Terminated |
NCT00566007 -
The Effect of Ozone Therapy for Lumbar Herniated Disc
|
Phase 2 |